ALZN
Income statement / Annual
Last year (2024), Alzamend Neuro, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Alzamend Neuro, Inc.'s net income was -$9.95 M.
See Alzamend Neuro, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
04/30/2024 |
04/30/2023 |
04/30/2022 |
04/30/2021 |
04/30/2020 |
04/30/2019 |
04/30/2018 |
04/30/2017 |
04/30/2016 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$50,740.00 |
$23,066.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$50,740.00 |
-$23,066.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$6.46 M
|
$7.45 M
|
$5.20 M
|
$1.31 M
|
$1.07 M
|
$3.70 M
|
$323,403.00
|
$275,047.00
|
$0.00
|
| General & Administrative
Expenses |
$3.48 M
|
$6.68 M
|
$7.12 M
|
$3.64 M
|
$3.35 M
|
$1.31 M
|
$545,118.00
|
$942,511.00
|
$69,456.00
|
| Selling & Marketing
Expenses |
$247,334.00
|
$742,601.00
|
$17,654.00
|
$0.00
|
$0.00
|
$0.00
|
$29,909.00
|
$330,839.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$3.48 M
|
$7.42 M
|
$7.12 M
|
$3.64 M
|
$3.35 M
|
$1.31 M
|
$575,027.00
|
$1.27 M
|
$69,456.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$9.94 M |
$14.87 M |
$12.32 M |
$4.95 M |
$4.42 M |
$5.01 M |
$898,430.00 |
$1.55 M |
$69,456.00 |
| Cost And Expenses |
$9.94 M |
$14.87 M |
$12.32 M |
$4.95 M |
$4.42 M |
$5.01 M |
$898,430.00 |
$1.55 M |
$69,456.00 |
| Interest Income |
$0.00 |
$7.70 |
$46.52 |
$1,706.00 |
$13,925.00 |
$146,387.00 |
$33,233.00 |
$21,501.00 |
$0.00 |
| Interest Expense |
$10,101.00 |
$7,701.00 |
$46,524.00 |
$158,803.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$50,740.00
|
$23,066.00
|
$3,549.00
|
$4.95 M
|
$4.42 M
|
$5.01 M
|
$898,430.00
|
$1.55 M
|
$69,456.00
|
| EBITDA |
-$9.89 M
|
-$14.85 M
|
-$12.32 M
|
$0.00
|
$0.00
|
$0.00
|
$7,341.00
|
-$21,501.00
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$10,101.00
|
-$7,701.00
|
-$42,524.00
|
-$94,679.00
|
$13,925.00
|
$146,387.00
|
-$33,233.00
|
-$21,501.00
|
$0.00
|
| Income Before Tax |
-$9.95 M |
-$14.88 M |
-$12.36 M |
-$5.05 M |
-$4.41 M |
-$4.86 M |
-$931,663.00 |
-$1.57 M |
-$69,456.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$144,829.00 |
$42,524.00 |
$157,097.00 |
-$13,925.00 |
-$146,387.00 |
-$898,430.00 |
-$21,501.00 |
$0.00 |
| Net Income |
-$9.95 M |
-$14.88 M |
-$12.40 M |
-$5.20 M |
-$4.40 M |
-$4.86 M |
-$931,663.00 |
-$1.57 M |
-$69,456.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-14.72 |
-22.89 |
-20.92 |
-10.75 |
-9.26 |
-12.4 |
-1.64 |
-8.18 |
-0.421 |
| EPS Diluted |
-14.7 |
-22.89 |
-20.88 |
-10.74 |
-9.25 |
-12.4 |
-1.64 |
-8.18 |
-0.42 |
| Weighted Average Shares
Out |
$676,000.00
|
$650,000.00
|
$593,000.00
|
$484,000.00
|
$475,000.00
|
$392,000.00
|
$568,696.00
|
$192,000.00
|
$165,000.00
|
| Weighted Average Shares
Out Diluted |
$676,565.00
|
$650,127.00
|
$593,969.00
|
$484,334.00
|
$475,024.00
|
$392,287.00
|
$568,696.00
|
$192,009.00
|
$165,298.00
|
| Link |
|
|
|
|
|
|
|
|
|
